Version June 2024
| Author Year | COI | Study design | Study | n | Findings | |||
| Cost | OR time | Complications | Pain, QOL | |||||
| Holleran TJ et al, 2021[1] | No | Retrospective, large database | O, L, R | O 100,880 L 18,035 R 6063 | Longer for R, but improved over study period (2008-2019) | Higher complication rate for R, but improved over study period (2008-2019) | ||
| Tatarian et al, 2021[2] | Yes | Retrospective, large database | O, L, R | O 117,603 L 35,565 R 559 | Unadjusted analysis: higher complication and recurrence rate at 5 years for R compared with O and L Propensity score analysis: no difference in outcomes or recurrences at 5 years | |||
| Zhao F et al, 2021[3] | No | Systematic review, meta-analysis | L, R | L 661 R 459 | Longer for R | Similar LOS and complication rate for L and R | Similar for L and R | |
| LeBlanc K et al, 2020[4] | Yes | Multicenter, prospective, nonrandomized, propensity matched | L: 19% TAPP; 81% TEP, R, O | L versus R: 80 each; L versus O: 112 each | R longer than O (74.0 versus 51.5 min); R longer than L (83.0 versus 65.0 min) | No difference | Greater need for pain medications in O versus R and L versus R; time to return to normal activities 3 days for R versus 4 days for O; no difference in time to return to normal activities for L versus R; higher QOL R versus O, no difference QOL L versus R | |
| Prabhu AS et al, 2020[5] | Yes | Multicenter, randomized | L-TAPP, R | L 54 R 48 | R higher ($3258 versus $1421, p<0.001) | R longer (75.5 versus 41.5 min, p<0.001) | No difference in wound events or readmissions | No difference |
| Sheldon RR et al, 2019[6] | No | Retrospective | O, L-TEP | R 49 O 9 L 34 | No difference in postoperative repeat opiate Rx | |||
| Abdelmoaty WF et al, 2018[7] | Yes | Retrospective cost-analysis | L | R 734 L 1671 | R higher average cost, lower average variable cost | R longer OR time | No difference in LOS, conversion to open | |
| Bittner JG et al, 2018[8] | Yes Robotic company employees | Prospective propensity for treatment matched | O, L | R 83 to 85 O 85 L 83 | Longer time from IHR to no Rx pain meds with O compared to L, R (p = 0.03); higher groin pain scores at 1 week with O compared to L, R (p<0.01); more activity disruption at 1 week with O compared to L, R (p<0.01) | |||
| Charles EJ et al, 2018[9] | Yes | Retrospective, NSQIP database | O, L | R 69 L 241 O 191 | No difference in postoperative occurrences, adverse events, readmissions | |||
| Gamagami R et al, 2018[10] | Yes | Retrospective, multicenter | O | R 652 O 602 | Longer skin-to-skin times for R (p<0.0001) | No difference in 30 day complications, readmissions, reoperations | ||
| Kolachalam R et al, 2018[11] | Yes | Retrospective propensity for treatment-matched | O | R 95 matched, 148 unadjusted O 93 matched, 113 unadjusted | Longer OR times for R (p<0.0001 unadjusted, p<0.001 matched) | Increased post-discharge complications to 30 days for O (p = 0.005 unadjusted, p = 0.047 matched) | ||
| Kosturakis AK et al, 2018[12] | No | Retrospective case-matched | O | R 100 O 100 | No difference in OR times | More multiple postoperative visits for pain for O IHR (p = 0.003) | ||
| Muysoms F et al, 2018[13] | Yes | Observational case control | L-TAPP | R 49 L 64 | No difference in OR time after learning curve | No difference in complications | ||
| Kudsi OY et al, 2017[14] | Yes | Retrospective single surgeon | L-TEP | R 118 L 157 | No difference | No difference in 30 day complications | ||
| Waite KE et al, 2016[15] | No | Retrospective | L-TAPP | R 39 L 24 | Cost per case was similar L and R when results separated into unilateral versus bilateral | Longer OR time for R (p<0.001 for unilateral, p = 0.004 for bilateral) | Recovery time, average pain were similar L and R when results separated into unilateral versus bilateral | |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
